SEC Form 4 · accession 0001225208-19-002349
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley McEvoy
Officer — EVP, WW Chair, Medical Devices
Period of report
Feb 8, 2019
Accepted (ET)
Feb 12, 2019 · 9:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | M | 6,599 | $0.00 | A | 16,092 | D | |
| Common StockF2 | Feb 8, 2019 | F | 1,824 | $132.00 | D | 14,268 | D | |
| Common StockF3 | Feb 11, 2019 | M | 7,541 | $0.00 | A | 21,809 | D | |
| Common StockF4 | Feb 11, 2019 | A | 1,237 | $0.00 | A | 23,046 | D | |
| Common StockF5 | Feb 11, 2019 | F | 3,578 | $131.94 | D | 19,468 | D | |
| Common StockF6 | holding | — | — | — | 2,243 | I | By 401k | |
| Common StockF7 | holding | — | — | — | 300 | I | By ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF8 | — | Feb 8, 2019 | M | 6,599 | D | Feb 8, 2019 | — | Common Stock | 6,599 | 0 | D |
| Employee Stock Options (Right to Buy)F9 | $131.94 | Feb 11, 2019 | A | 58,972 | A | Feb 11, 2022 | Feb 11, 2029 | Common Stock | 58,972 | 58,972 | D |
| Performance Share UnitsF3 | — | Feb 11, 2019 | M | 7,541 | D | Feb 8, 2019 | — | Common Stock | 7,541 | 0 | D |
| Restricted Share UnitsF10 | — | Feb 11, 2019 | A | 2,885 | A | Feb 11, 2022 | — | Common Stock | 2,885 | 2,885 | D |
Explanation of responses
- F1Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting.
- F10Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
- F2Shares withheld for payment of taxes upon vesting of Restricted Share Units.
- F3Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.
- F4Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.
- F5Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
- F6Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019).
- F7Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019).
- F8Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 8, 2016, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date.
- F9Awarded under Issuer's Long-Term Incentive Plan.
Remarks
poamcevoy.txt